Targeting BCL-2 as a Therapeutic Strategy for Primary P210BCR-Abl1-Positive B-All Cells
In Vivo - Greece
doi 10.21873/invivo.11802
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
Anticancer Research USA Inc.
Available in full text
January 1, 2020
Anticancer Research USA Inc.